Published May 8, 2026 | Version v1

Evolving Methods In Fibrosis Quantification: A Scoping Review Of Histologic, Imaging, And Ai-enhanced Modalities Across Systems

  • 1. Chicago Medical School - RFUMS, North Chicago, IL, USA
  • 2. Florida International University Herbert Wertheim College of Medicine,, Miami, FL, USA
  • 3. Carle Illinois College of Medicine, Urbana, IL, USA
  • 4. Northwestern University Feinberg School of Medicine; Chicago Medical School - RFUMS, North Chicago, IL, USA

Description

Background: Fibrosis, defined by excessive extracellular matrix (ECM) deposition, is a key pathological feature of chronic inflammation, injury, and altered tissue architecture. Consequentially, individuals experience limited regenerative capacity in wound healing, tissue viability, and aesthetic outcomes. Despite clinical and surgical relevance, methods to quantify fibrosis across tissue types remain fragmented and inconsistent. Objective: This scoping review synthesizes current and emerging methods for fibrosis quantification, emphasizing advances in histologic assessment, imaging, and artificial intelligence (AI) driven modalities applicable to surgical and translational research enhancement. Methods: A systematic literature review in accordance with PRISMA-ScR guidelines was conducted across PubMed, Embase, and Cochrane databases. Studies describing histological scoring systems, digital image analysis, radiographic techniques, novel microscopy, and AI-based models for fibrosis quantification were included. Emphasis was placed on modalities with relevance to dermal, cardiac, hepatic, renal, and pulmonary tissues along with key analogs for reconstructive applications. Results: Conventional histologic scoring remains the reference standard but is limited by subjectivity and variability. While imaging modalities provide non-invasive assessment, they lack in cellular-level resolution. Rapidly developing AI-enhanced approaches, particularly convolutional neural networks and radiomics, enable automated, high-throughput fibrosis detection and staging. Tools such as FIBER-ML and qFibrosis exemplify how machine learning improves reproducibility and standardization. Novel label-free imaging and omics-based biomarker panels show additional promise. Conclusion: Integration of AI with histologic and imaging modalities marks a significant advancement for fibrosis quantification. These evolving methods offer scalable, precise assessment strategies with cross-disciplinary utility in diagnostics, research, and future clinical decision-making. *Source: https://ps-rc.org/meeting/Program/2026/AS59.cgi*

Notes

Abstract ID: AS59

Files

PSRC2026_AS59.txt

Files (2.7 kB)

Name Size
md5:83e5403939ab9951ce76edfd2f9ad84a
2.7 kB Preview Download